Simulations Plus Other Operating Income or Expenses 2010-2025 | SLP
Simulations Plus other operating income or expenses from 2010 to 2025. Other operating income or expenses can be defined as the aggregate amount of all operating expenses either too small to report separately or that cannot be standardized into another Zacks field.
Simulations Plus Annual Other Operating Income or Expenses
(Millions of US $) |
| 2024 |
$0 |
| 2023 |
$0 |
| 2022 |
$0 |
| 2021 |
$0 |
| 2020 |
$0 |
| 2019 |
$0 |
| 2018 |
$0 |
| 2017 |
$0 |
| 2016 |
$0 |
| 2015 |
$0 |
| 2014 |
$0 |
| 2013 |
$0 |
| 2012 |
$0 |
| 2011 |
$0 |
| 2010 |
$0 |
| 2009 |
$0 |
Simulations Plus Quarterly Other Operating Income or Expenses
(Millions of US $) |
| 2025-02-28 |
|
| 2024-11-30 |
|
| 2024-08-31 |
|
| 2024-05-31 |
|
| 2024-02-29 |
|
| 2023-11-30 |
|
| 2023-08-31 |
|
| 2023-05-31 |
|
| 2023-02-28 |
|
| 2022-11-30 |
|
| 2022-08-31 |
|
| 2022-05-31 |
|
| 2022-02-28 |
|
| 2021-11-30 |
|
| 2021-08-31 |
|
| 2021-05-31 |
|
| 2021-02-28 |
|
| 2020-11-30 |
|
| 2020-08-31 |
|
| 2020-05-31 |
|
| 2020-02-29 |
|
| 2019-11-30 |
|
| 2019-08-31 |
|
| 2019-05-31 |
|
| 2019-02-28 |
|
| 2018-11-30 |
|
| 2018-08-31 |
|
| 2018-05-31 |
|
| 2018-02-28 |
|
| 2017-11-30 |
|
| 2017-08-31 |
|
| 2017-05-31 |
|
| 2017-02-28 |
|
| 2016-11-30 |
|
| 2016-08-31 |
|
| 2016-05-31 |
|
| 2016-02-29 |
|
| 2015-11-30 |
|
| 2015-08-31 |
|
| 2015-05-31 |
|
| 2015-02-28 |
|
| 2014-11-30 |
|
| 2014-08-31 |
|
| 2014-05-31 |
|
| 2014-02-28 |
|
| 2013-11-30 |
|
| 2013-08-31 |
|
| 2013-05-31 |
|
| 2013-02-28 |
|
| 2012-11-30 |
|
| 2012-08-31 |
|
| 2012-05-31 |
|
| 2012-02-29 |
|
| 2011-11-30 |
|
| 2011-08-31 |
|
| 2011-05-31 |
|
| 2011-02-28 |
|
| 2010-11-30 |
|
| 2010-08-31 |
|
| 2010-05-31 |
|
| 2010-02-28 |
|
| 2009-11-30 |
|
| 2009-08-31 |
|
| 2009-05-31 |
|
| 2009-02-28 |
|
| Sector |
Industry |
Market Cap |
Revenue |
| Computer and Technology |
Computer Software |
$0.554B |
$0.070B |
|
Simulations Plus, Inc., is a premier developer of groundbreaking drug discovery and development simulation software, which is licensed to and used in the conduct of drug research by major pharmaceutical and biotechnology companies worldwide. They have two other businesses, Words+, Inc. and FutureLab, which are based on its proprietary software technologies.
|
